![The evolving story of incretins (GIP and GLP‐1) in metabolic and cardiovascular disease: A pathophysiological update - Nauck - 2021 - Diabetes, Obesity and Metabolism - Wiley Online Library The evolving story of incretins (GIP and GLP‐1) in metabolic and cardiovascular disease: A pathophysiological update - Nauck - 2021 - Diabetes, Obesity and Metabolism - Wiley Online Library](https://dom-pubs.onlinelibrary.wiley.com/cms/asset/414ba3e0-5948-4dd5-a9ba-672073b1496d/dom14496-fig-0002-m.jpg)
The evolving story of incretins (GIP and GLP‐1) in metabolic and cardiovascular disease: A pathophysiological update - Nauck - 2021 - Diabetes, Obesity and Metabolism - Wiley Online Library
![Tirzepatide, a dual GIP/GLP-1 receptor co-agonist for the treatment of type 2 diabetes with unmatched effectiveness regrading glycaemic control and body weight reduction | Cardiovascular Diabetology | Full Text Tirzepatide, a dual GIP/GLP-1 receptor co-agonist for the treatment of type 2 diabetes with unmatched effectiveness regrading glycaemic control and body weight reduction | Cardiovascular Diabetology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12933-022-01604-7/MediaObjects/12933_2022_1604_Fig1_HTML.png)
Tirzepatide, a dual GIP/GLP-1 receptor co-agonist for the treatment of type 2 diabetes with unmatched effectiveness regrading glycaemic control and body weight reduction | Cardiovascular Diabetology | Full Text
![Efficacy and safety of LY3298176, a novel dual GIP and GLP-1 receptor agonist, in patients with type 2 diabetes: a randomised, placebo-controlled and active comparator-controlled phase 2 trial - The Lancet Efficacy and safety of LY3298176, a novel dual GIP and GLP-1 receptor agonist, in patients with type 2 diabetes: a randomised, placebo-controlled and active comparator-controlled phase 2 trial - The Lancet](https://www.thelancet.com/cms/attachment/5edca10b-eaf1-4d99-aa22-bc0fe35aeb00/gr1.gif)
Efficacy and safety of LY3298176, a novel dual GIP and GLP-1 receptor agonist, in patients with type 2 diabetes: a randomised, placebo-controlled and active comparator-controlled phase 2 trial - The Lancet
![Gksz Ipari terület Általános Gip-1 Településgazdálkodási Gip-2 K ü l ö n l e g e s t e r ü l e t Sportterület Ksp-1. Ksp-2 Temető - PDF Ingyenes letöltés Gksz Ipari terület Általános Gip-1 Településgazdálkodási Gip-2 K ü l ö n l e g e s t e r ü l e t Sportterület Ksp-1. Ksp-2 Temető - PDF Ingyenes letöltés](https://docplayer.hu/docs-images/43/1622065/images/page_1.jpg)
Gksz Ipari terület Általános Gip-1 Településgazdálkodási Gip-2 K ü l ö n l e g e s t e r ü l e t Sportterület Ksp-1. Ksp-2 Temető - PDF Ingyenes letöltés
![Biology | Free Full-Text | Gastrointestinal Incretins—Glucose-Dependent Insulinotropic Polypeptide (GIP) and Glucagon-like Peptide-1 (GLP-1) beyond Pleiotropic Physiological Effects Are Involved in Pathophysiology of Atherosclerosis and Coronary ... Biology | Free Full-Text | Gastrointestinal Incretins—Glucose-Dependent Insulinotropic Polypeptide (GIP) and Glucagon-like Peptide-1 (GLP-1) beyond Pleiotropic Physiological Effects Are Involved in Pathophysiology of Atherosclerosis and Coronary ...](https://www.mdpi.com/biology/biology-11-00288/article_deploy/html/images/biology-11-00288-g001.png)
Biology | Free Full-Text | Gastrointestinal Incretins—Glucose-Dependent Insulinotropic Polypeptide (GIP) and Glucagon-like Peptide-1 (GLP-1) beyond Pleiotropic Physiological Effects Are Involved in Pathophysiology of Atherosclerosis and Coronary ...
![The evolving story of incretins (GIP and GLP‐1) in metabolic and cardiovascular disease: A pathophysiological update - Nauck - 2021 - Diabetes, Obesity and Metabolism - Wiley Online Library The evolving story of incretins (GIP and GLP‐1) in metabolic and cardiovascular disease: A pathophysiological update - Nauck - 2021 - Diabetes, Obesity and Metabolism - Wiley Online Library](https://dom-pubs.onlinelibrary.wiley.com/cms/asset/4d065d23-33ad-42b7-bfbc-8a244219872f/dom14496-fig-0004-m.jpg)
The evolving story of incretins (GIP and GLP‐1) in metabolic and cardiovascular disease: A pathophysiological update - Nauck - 2021 - Diabetes, Obesity and Metabolism - Wiley Online Library
![GIP and GLP‐1, the two incretin hormones: Similarities and differences - Seino - 2010 - Journal of Diabetes Investigation - Wiley Online Library GIP and GLP‐1, the two incretin hormones: Similarities and differences - Seino - 2010 - Journal of Diabetes Investigation - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/17f97155-8c0a-4d47-98b1-56ef9893b303/jdi_22_f2.gif)
GIP and GLP‐1, the two incretin hormones: Similarities and differences - Seino - 2010 - Journal of Diabetes Investigation - Wiley Online Library
![Total Glucose-dependent Insulinotropic Peptide (GIP) ELISA, 27203 (RUO) | Human Total GIP (Gastric Inhibitory Polypeptide) Competitive Enzyme-linked Immune-sorbent Assay Kit IBL-America Total Glucose-dependent Insulinotropic Peptide (GIP) ELISA, 27203 (RUO) | Human Total GIP (Gastric Inhibitory Polypeptide) Competitive Enzyme-linked Immune-sorbent Assay Kit IBL-America](https://cdn11.bigcommerce.com/s-dpaty9ionu/images/stencil/1280x1280/products/5808/13955/pancreas2__49390.1635962302.png?c=2)
Total Glucose-dependent Insulinotropic Peptide (GIP) ELISA, 27203 (RUO) | Human Total GIP (Gastric Inhibitory Polypeptide) Competitive Enzyme-linked Immune-sorbent Assay Kit IBL-America
![Two incretin hormones GLP-1 and GIP: comparison of their actions in insulin secretion and β cell preservation. | Semantic Scholar Two incretin hormones GLP-1 and GIP: comparison of their actions in insulin secretion and β cell preservation. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/852ca66060ffdba66beb14e27e19fbc2a63a970f/3-Figure2-1.png)
Two incretin hormones GLP-1 and GIP: comparison of their actions in insulin secretion and β cell preservation. | Semantic Scholar
![Two incretin hormones GLP-1 and GIP: Comparison of their actions in insulin secretion and β cell preservation - ScienceDirect Two incretin hormones GLP-1 and GIP: Comparison of their actions in insulin secretion and β cell preservation - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0079610711000812-gr3.jpg)